In August CTS begins source plasma testing as a new line of business to one of the largest plasma fractionators in the industry.
Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...